Introduction
Retinopathy of prematurity (ROP) occurs exclusively in preterm infants with low gestational age (GA) and low birth weight. Threshold ROP occurs in approximately 5% infants of birth weight <1250 g, 1 10 to 15% will become blind despite treatment. 2 Severe or progressive ROP usually occurs in the very small and very sick babies. 3 We present an unusual case of ROP in an infant with a birth weight of 2102 g. Case A female infant who was born at 30 (2) weeks' gestation and of birth weight 2102 g was screened for ROP. 4 On the first screening at 36 weeks GA she was found to have 12 clock hours of stage 2 ROP bilaterally. Later she was found to have developed 3 clock hours of stage 3 and 2 clock hours of stage 3 ROP in the right and left eye, respectively. The retinopathy regressed spontaneously with subsequent normal retinal vascularization.
She had unexplained hydrops and bilateral pelvicalceal dilation. These features prompted karyotyping. Chromosomal analysis detected an unbalanced translocation 18p (monosomy) and 6p (trisomy). 6p12 codes for vasculo endothelial growth factor (VEGF). VEGF polymorphism analysis was performed in order to rule out overexpression.
DNA was extracted from buccal cells and screened by single-strand conformation polymorphism (SSCP) analysis for the À634 G>C and 936 C>T VEGF gene polymorphisms. 5 Sequencing was then performed to confirm the À634 G>C genotype.
Using SSCP, the 936 C>T genotype was C/C/C. Sequencing showed the À634 G>C genotype to be G/G/G (Figure 1 ).
Discussion
Birth weight and GA are the most significant risk factors in the aetiology of ROP. 6, 7 Stage 3 ROP is unusual in babies born at or after 30 weeks gestation. Our unit has screened 2960 infants of whom stage 3 ROP has been found in five other babies with birth weight >1500 g. Their birth weights and GA were as follows: 1502 g, GA 32 weeks; 1560 g, GA 31 weeks; 1600 g, GA 31 weeks; 1600 g, GA 30 weeks; 1800 g, GA 31 weeks. The baby of birth weight 1800 g was Figure 1 VEGF polymorphism in our case.
an extremely sick baby with severe respiratory distress syndrome and died before 3 months of age. Jandeck et al. 8 report three cases of ROP in infants of birth weight >2000 g. In their series all the babies had suffered haemorrhagic shock and required blood transfusion immediately after birth.
The infant described in our case was at relatively low risk of developing ROP. She was conceived normally. 9 She was born at 30 (2) weeks' gestation and was >2000 g at birth. The infant had respiratory distress syndrome and required assisted ventilation for 7 days. She did not require re-ventilation and had not suffered prolonged anoxic or hyperoxic states both of which are known to be associated with ROP. 10, 11 Other perinatal factors were hyponatremia, hypoglycaemia, conjugated hyperbilirubinemia, compensated acute renal failure, bilateral intraventricular haemorrhage and staphylococcal sepsis. These features are not uncommon in preterm babies and have not found to be independent risk factors in the development of ROP.
VEGF is a protein that acts specifically on endothelial cells. It increases vascular permeability and induces angiogenesis, vasculogenesis and endothelial cell growth. Previous work on our unit investigated the frequency of two common VEGF polymorphisms in infants with threshold ROP compared with those infants who did not develop ROP, or whose ROP regressed spontaneously. 5 The genotype at position À634 (G>C) in the 5 0 untranslated region and *936 (C>T) in the 3 0 untranslated region had been shown to be related to changes in VEGF production in vitro and in vivo, respectively. We found that homozygotes for the G allele at À634, associated with higher VEGF production, were twice as likely to have threshold ROP as those with other genotypes. We think that overexpression of VEGF was a contributory factor to the development of ROP in this case.
In some premature infants ROP progresses despite rigorous and timely intervention whereas in others these clinical features regress spontaneously. Similarly, ROP occasionally occurs unexpectedly in babies with higher birth weights and GA. At least in some such cases, genetic polymorphisms may alter the function of genes that control normal retinal vascularization.
It has been suggested in some studies that birth weight of less than 1251 g and GA less than 30 weeks can be safely and efficiently used to screen babies without missing sight-threatening ROP. 11, 12 Though birth weight and GA are the two most important independent risk factors for this disease, not all factors contributing to the cause of ROP are yet known. The desire to decrease the number of unaffected babies to be screened should not prevent us from missing some of those cases that may provide valuable insight into the pathogenesis of this disease.
